studi
aim
assess
clinic
characterist
thelper
profil
human
rhinoviru
hrv
infect
children
bronchiol
pneumonia
compar
respiratori
syncyti
viru
rsv
septemb
august
nasopharyng
aspir
children
bronchiol
pneumonia
screen
hrv
respiratori
virus
pcr
revers
transcript
pcr
interferon
ifn
interleukin
il
tumor
necrosi
factor
tnf
detect
multiplex
enzymelink
immunosorb
assay
hrv
found
case
includ
bronchiol
pneumonia
case
compar
rsv
alon
group
children
pneumonia
frequent
wheez
episod
hrv
p
hrv
nonrsv
p
b
group
fever
hrv
p
f
hrv
rsv
p
g
group
among
patient
bronchiol
case
hrv
alon
like
present
winter
rsv
alon
p
hrv
nonrsv
p
j
less
numer
summer
compar
hrv
nonrsv
p
h
children
hrv
alon
suscept
histori
eczema
rsv
alon
among
bronchiol
p
c
pneumonia
p
e
case
hrv
bronchiol
case
increas
decreas
ratio
compar
hrv
pneumonia
counterpart
hrv
major
nonrsv
pathogen
caus
hospit
children
bronchiol
pneumonia
induc
imbalanc
respons
bronchiol
compar
rsv
infect
hrv
bronchiol
pneumonia
differ
significantli
regard
wheez
episod
suscept
eczema
fever
occurr
season
preval
k
e
w
r
human
rhinoviru
infect
immun
respons
introduct
human
rhinoviru
hrv
commonli
detect
respiratori
viru
children
individu
year
age
experienc
least
one
episod
hrv
infect
previou
find
show
rate
hrv
caus
bronchiol
viral
cap
hospit
children
reach
respect
reveal
hrv
common
etiolog
agent
two
diseas
howev
hrv
coinfect
virus
bacteria
frequent
especi
respiratori
syncyti
viru
rsv
clinic
featur
diseas
sever
hrv
infect
differ
among
studi
abbrevi
hrvb
human
rhinoviru
bronchiol
hrvp
human
rhinoviru
pneumonia
rsvb
respiratori
syncyti
viru
bronchiol
rsvp
respiratori
syncyti
viru
pneumonia
clinic
immun
respons
featur
hospit
children
human
rhinoviru
infect
j
med
hrv
belong
enteroviru
genu
picornavirida
famili
genet
divers
base
phylogenet
sequenc
criteria
hrv
classifi
three
speci
includ
hrva
hrvbronchiol
hrvb
hrvc
distinct
serotyp
accord
surfac
protein
preval
diseas
sever
bronchiol
pneumonia
induc
hrva
hrvc
higher
involv
hrvb
previou
studi
demonstr
hrvb
exhibit
lower
slower
replic
less
cytopath
effect
exposur
airway
epitheli
cell
hrv
lead
releas
proinflammatori
product
relat
pathogen
mechan
help
initi
antivir
respons
thelper
imbal
play
import
role
immun
respons
viral
infect
asthma
develop
previou
find
indic
rhinoviru
rsv
bronchiol
earli
life
associ
increas
risk
asthma
wheez
induc
hrv
young
children
import
predict
factor
recurr
wheez
therefor
understand
clinic
associ
immunolog
featur
hrv
would
help
prevent
treat
hrv
respiratori
diseas
studi
aim
assess
epidemiolog
clinic
characterist
hrv
infect
determin
cytokin
profil
hrv
infect
children
bronchiol
pneumonia
show
underli
diseas
includ
asthma
congenit
heart
diseas
immunodefici
diseas
bronchopulmonari
dysplasia
pneumonia
defin
acut
respiratori
infect
pulmonari
infiltr
chest
xray
diagnos
radiologist
bronchiol
diagnos
presenc
wheez
combin
tachypnea
atelectasi
peribronchi
thicken
chest
xray
children
age
year
ten
healthi
children
without
histori
recurr
wheez
respiratori
infect
symptom
within
week
children
health
clinic
recruit
control
group
cytokin
detect
demograph
data
clinic
find
medic
test
result
collect
standard
form
inform
consent
obtain
parent
enrol
children
studi
protocol
approv
hospit
ethic
committe
nasopharyng
aspir
npa
collect
inpati
day
admiss
alongsid
healthi
children
children
health
clinic
sampl
transfer
viru
transport
medium
store
process
dna
rna
extract
ml
npa
qiaamp
viral
dna
minikit
qiaamp
viral
rna
minikit
qiagen
nanj
china
respect
primer
use
amplifi
pair
fragment
hrv
forward
revers
describ
previous
next
npa
specimen
patient
infect
either
hrv
rsv
alon
healthi
children
select
cytokin
detect
statist
analysi
perform
spss
version
demograph
clinic
paramet
compar
among
hrv
alon
rsv
alon
hrv
rsv
hrv
nonrsv
group
test
appli
categor
variabl
student
test
nonparametr
kruskalw
test
use
continu
variabl
appropri
comparison
cytokin
concentr
group
perform
use
nonparametr
mannwhitney
u
test
twotail
p
consid
statist
signific
inpati
male
indic
malefemal
ratio
similar
p
howev
rsv
like
associ
bronchiol
pneumonia
p
coinfect
case
involv
hrv
includ
rsv
adv
hmpv
adv
adv
rsv
adv
hbov
case
next
lrti
case
assess
sputum
bacteria
cultur
total
hrv
case
coinfect
bacteria
includ
three
haemophilu
influenza
two
klebsiella
pneumonia
one
streptococcu
pneumonia
preval
cycl
hrv
rsv
associ
bronchiol
pneumonia
present
figur
sinc
hrv
coinfect
virus
frequent
rsv
common
copathogen
evalu
clinic
characterist
children
hrv
rsv
singl
infect
well
hrv
case
coinfect
without
rsv
tabl
mean
age
age
distribut
patient
bronchiol
pneumonia
similar
among
variou
viral
group
p
furthermor
children
hrv
infect
frequent
wheez
episod
compar
rsv
p
hrv
nonrsv
p
b
infect
among
pneumonia
case
compar
group
among
bronchiol
case
p
children
histori
eczema
present
current
ill
like
infect
hrv
rsv
p
c
hrv
nonrsv
p
among
bronchiol
case
similar
result
found
children
pneumonia
p
e
median
length
hospit
stay
lo
valu
hrv
alon
case
bronchiol
pneumonia
respect
ident
day
similar
group
lo
seven
differ
bronchiol
pneumonia
case
among
hrv
alon
viral
group
p
signific
differ
found
term
supplement
oxygen
tachypnea
white
blood
count
among
hrv
three
group
p
children
pneumonia
hrv
group
like
fewer
rsv
p
f
hrv
rsv
p
g
group
hrv
associ
pneumonia
less
like
occur
summer
month
hrv
nonrsv
p
h
hrv
associ
bronchiol
like
occur
winter
month
rsv
p
hrv
nonrsv
p
j
age
mean
sd
present
studi
hrv
found
children
lower
respiratori
infect
lri
detect
rate
similar
bronchiol
pneumonia
case
result
reveal
hrv
major
viral
etiolog
pneumonia
also
second
lead
caus
bronchiol
rsv
corrobor
previou
studi
unlik
rsv
hrv
show
similar
incid
rate
bronchiol
pneumonia
case
mani
prospect
longterm
studi
shown
rsvinduc
bronchiol
associ
later
develop
asthma
howev
recent
cohort
studi
suggest
infant
wheez
result
hrv
infect
may
greater
risk
subsequ
asthma
compar
rsv
piv
influenza
virusinfect
counterpart
therefor
hrv
caus
lower
respiratori
tract
ill
also
repres
signific
pathogen
previou
data
reveal
hrv
circul
yearround
prevail
fall
winter
season
distribut
hrv
vari
f
g
u
r
e
b
elev
cytokin
level
nasopharyng
aspir
hrv
rsv
induc
bronchiol
pneumonia
compar
control
hrv
human
rhinoviru
rsv
respiratori
syncyti
viru
accord
geograph
area
well
result
diseas
studi
show
hrvinduc
pneumonia
bronchiol
preval
winter
spring
hrvc
incid
peak
winter
late
spring
month
hrva
detect
mainli
autumn
spring
month
gener
agreement
find
other
previou
studi
report
season
distribut
hrv
consist
asthma
occurr
hospit
children
indic
hrv
infect
like
caus
sever
ill
winter
season
studi
demonstr
epidem
season
hrv
predominantli
winter
spring
month
accord
episod
bronchiol
pneumonia
case
therefor
rhinoviru
import
pathogen
caus
bronchiol
pneumonia
children
winter
spring
present
studi
mean
age
age
distribut
similar
among
hrv
alon
rsv
alon
group
consist
previou
studi
contrast
find
patient
hrvinduc
lower
respiratori
tract
infect
lrti
tend
older
rsv
case
may
relat
differ
studi
design
patient
hrv
singl
infect
present
often
histori
eczema
rsv
hrv
nonrsv
group
accord
find
multicent
studi
furthermor
coast
studi
evalu
relationship
hrv
ill
allerg
sensit
show
allerg
sensit
may
preced
rhinoviru
associ
wheez
rsv
infect
moreov
recent
studi
show
major
hrvinfect
infant
display
high
respons
major
rsvinfect
infant
show
respons
current
studi
ratio
higher
hrv
rsv
associ
f
g
u
r
e
ratio
nasopharyng
aspir
hrv
rsv
induc
bronchiol
pneumonia
control
median
repres
horizont
bar
note
data
figur
analyz
mannwhitney
u
test
kruskalw
test
p
p
p
rsvb
bronchiol
case
rsv
alon
rsvp
pneumonia
case
rsv
alon
hrvb
bronchiol
case
hrv
alon
hrvp
pneumonia
case
hrv
alon
hrvb
human
rhinoviru
bronchiol
il
interleukin
rsvb
respiratori
syncyti
viru
bronchiol
rsvp
respiratori
syncyti
viru
pneumonia
tnf
tumor
necrosi
factor
bronchiol
compar
pneumonia
control
case
reflect
increas
decreas
ratio
suggest
excess
defici
respons
may
associ
pathogenesi
hrv
bronchiol
reason
ratio
significantli
differ
bronchiol
pneumonia
case
hrv
rsv
group
difficult
explain
howev
may
explain
repres
potent
mediat
cellular
commun
crucial
regul
innat
adapt
inflammatori
respons
posit
associ
ill
sever
rsv
hrv
associ
lower
respiratori
tract
infect
taken
togeth
imbalanc
respons
play
import
role
pathogenesi
hrv
bronchiol
may
one
reason
asthma
develop
studi
potenti
limit
first
test
concurr
healthi
control
determin
preval
asymptomat
rhinoviru
shed
anoth
limit
low
number
subject
viru
group
cytokin
detect
assay
sinc
case
recruit
singl
viru
infect
similar
background
conclus
studi
show
hrv
second
